Most Viewed Abstracts
1. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 2. Omega-3 fatty acids for bipolar disorder 3. Is folic acid good for everyone 4. ACS Releases Guidelines for HPV Vaccination 5. Vitamin D - A review Free full text
Your Article Summary
Review: adding dexamethasone to standard therapy reduces short-term relapse for acute migraine in the emergency department
Evidence-Based Medicine, 08/10/09
Carpenter CR – In patients presenting to the emergency department with acute migraine headache, adding dexamethasone to standard therapy reduces short–term relapse.
Methods- Randomised controlled trials (RCTs) in which patients and treating physicians were blinded were retrieved from Medline (1950–May 2008); EMBASE/Excerpta Medica, CINAHL, LILACS, and Cochrane Central Register of Controlled Trials {all to May 2008}*; ClinicalTrials.gov; reference lists; and abstracts from major emergency medicine conferences published in the past 7 years.
- Authors were contacted for additional information.
- 7 trials (n = 742), including 2 reported only as abstracts, met the selection criteria: 3 used a 5–point headache severity scale, 3 used a 4–point scale, and 1 used a dichotomous outcome.
- 5 trials gave dexamethasone (8–24 mg) as a single intravenous injection, 1 gave the drug (20 mg) intravenously or intramuscularly, and 1 used oral tablets (8 mg).
- All studies were high quality (Jadad scale scores 5 out of 5).
- Meta–analysis showed that adding dexamethasone to standard therapy for migraine reduced moderate–to–severe headaches at 24–72 hours.
- Adverse events occurred in 26% of patients in the dexamethasone group and 23% in the placebo group but were not clearly reported in all trials.
Related Articles
Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trial : The Lancet Oncology
The Lancet Oncology - Online First, 10/23/09
Relevance Score: 94%
Survival effect of venous thromboembolism in patients with multiple myeloma treated with lenalidomide and high-dose dexamethasone
Journal of Clinical Oncology, 11/13/09
Relevance Score: 91%
The Effect of Topical Combined Ciprofloxacin 0.3% and Dexamethasone 0.1% on Children with Otitis Media with Effusion(OME) Undergoing Myringotomy
Middle East Journal of Family Medicine, 10/21/09
Relevance Score: 88%
Phase 2 trial results with the novel neurokinin-1 receptor antagonist casopitant in combination with ondansetron and dexamethasone for the prevention of chemotherapy-induced nausea and vomiting in cancer patients receiving moderately emetogenic chemotherapy
Cancer, 10/20/09
Relevance Score: 88%
Dexamethasone decreases oxycodone consumption following osteotomy of the first metatarsal bone: a randomized controlled trial in day surgery
Acta Anaesthesiologica Scandinavica, 10/30/09
Relevance Score: 87%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Comparison of the efficacy of administering a combination of ezetimibe plus fenofibrate versus atorvastatin monotherapy in the treatment of dyslipidemia
Lipids in Health and Disease, 12/20/09
Grip strength and cardiovascular drug use in older people: findings from the Hertfordshire Cohort Study
Age and Aging, 12/20/09
Efficacy of escalated imatinib combined with cytarabine in newly diagnosed patients with chronic myeloid leukemia
Haematologica, 12/20/09
Today in Critical Care/Emergency...keeping you current
Receive free subspecialty "5-minute updates" via email
Study of risk factors affecting the survival rate of emergency victims with "chest pain" as chief complaint
Indian Journal of Community Medicine, 12/20/09
Gender differences in patients with acute ischemic stroke
Women's Health, 12/18/09
Emotional Regulation and Acute Pain Perception in Women
The Journal of Pain, 12/17/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


